Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway
Condition(s):Castration-resistant Prostate Cancer; MetastasisLast Updated:April 30, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Castration-resistant Prostate Cancer; MetastasisLast Updated:April 30, 2021Terminated
Condition(s):Metastatic Prostate CancerLast Updated:December 12, 2017Terminated
Condition(s):Prostate CancerLast Updated:February 26, 2014Terminated
Condition(s):Metastatic Prostate CancerLast Updated:February 24, 2010Completed
Condition(s):Prostate CancerLast Updated:December 15, 2021Completed
Condition(s):Prostate Cancer Metastatic; Castration-resistant Prostate CancerLast Updated:February 16, 2024Completed
Condition(s):Prostate Cancer; Recurrent Prostate CancerLast Updated:December 4, 2023Recruiting
Condition(s):Bone Metastatic Prostate CancerLast Updated:February 10, 2020Completed
Condition(s):Prostate CancerLast Updated:May 9, 2023Not yet recruiting
Condition(s):High Risk Prostate Carcinoma; Biochemically Recurrent Prostate Carcinoma; Castration-resistant Prostate Cancer; Prostate CancerLast Updated:September 5, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.